| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/21/2022 | — | Maxim Group | Downgrades | Buy → Hold | |
| 05/13/2022 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 04/01/2022 | 763.31% | Stephens & Co. | $14 → $12 | Maintains | Overweight |
| 04/01/2022 | 511.51% | HC Wainwright & Co. | $20 → $8.5 | Maintains | Buy |
| 02/10/2022 | 1338.85% | HC Wainwright & Co. | $43 → $20 | Maintains | Buy |
| 11/16/2021 | 2993.53% | HC Wainwright & Co. | $46 → $43 | Maintains | Buy |
| 07/27/2021 | 1914.39% | Stephens & Co. | → $28 | Initiates Coverage On | → Overweight |
| 03/11/2021 | 2777.7% | Maxim Group | → $40 | Initiates Coverage On | → Buy |
| 01/26/2021 | 2777.7% | HC Wainwright & Co. | $16 → $40 | Maintains | Buy |
| 05/12/2020 | 1051.08% | HC Wainwright & Co. | $6 → $16 | Upgrades | Neutral → Buy |
| 02/14/2020 | 331.65% | HC Wainwright & Co. | → $6 | Downgrades | Buy → Neutral |
| 02/25/2019 | — | HC Wainwright & Co. | Initiates Coverage On | → Buy |
Pulse Biosciences Questions & Answers
The latest price target for Pulse Biosciences (NASDAQ: PLSE) was reported by Maxim Group on September 21, 2022. The analyst firm set a price target for $0.00 expecting PLSE to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Pulse Biosciences (NASDAQ: PLSE) was provided by Maxim Group, and Pulse Biosciences downgraded their hold rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pulse Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pulse Biosciences was filed on September 21, 2022 so you should expect the next rating to be made available sometime around September 21, 2023.
While ratings are subjective and will change, the latest Pulse Biosciences (PLSE) rating was a downgraded with a price target of $0.00 to $0.00. The current price Pulse Biosciences (PLSE) is trading at is $1.39, which is out of the analyst's predicted range.
